CVS Health Corporation (CVS)
| Market Cap | 102.72B |
| Revenue (ttm) | 391.69B |
| Net Income (ttm) | 469.00M |
| Shares Out | 1.27B |
| EPS (ttm) | 0.37 |
| PE Ratio | 218.75 |
| Forward PE | 11.74 |
| Dividend | $2.66 (3.28%) |
| Ex-Dividend Date | Oct 23, 2025 |
| Volume | 6,225,657 |
| Open | 79.71 |
| Previous Close | 79.87 |
| Day's Range | 79.65 - 81.72 |
| 52-Week Range | 43.56 - 85.15 |
| Beta | 0.48 |
| Analysts | Strong Buy |
| Price Target | 86.68 (+7.12%) |
| Earnings Date | Oct 29, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for CVS stock is "Strong Buy." The 12-month stock price target is $86.68, which is an increase of 7.12% from the latest price.
News
Eli Lilly drops CVS drug plan for workers after Novo obesity deal, Bloomberg News reports
Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk , Bloomberg News reported on Tue...
Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
CVS Health to hold Investor Day on December 9, 2025
WOONSOCKET, R.I. , Nov. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold its Investor Day on December 9 th, 2025.
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CV...
CVS Health: Undervalued And Ripe For Growth
CVS Health offers a compelling value and income opportunity, trading at a forward P/E under 12 with a 3.4% dividend yield. It delivered strong Q3 results, driven by Aetna's insurance segment and momen...
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting ...
My Top 10 High-Yield Picks For November 2025: One Yields 9%+
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, a...
Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript
CVS Health Corporation ( CVS) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO J. Joyn...
CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High
CVS Health Corp (NYSE:CVS) on Wednesday reported better-than-expected third-quarter earnings and raised its annual guidance.
CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings
CVS Health's stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report.
CVS Posts Loss on Write-Down, Boosts Guidance
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
CVS Reports Big Loss On Devalued Oak Street Clinics But Aetna Costs Are Stable
CVS Health Wednesday reported a $4 billion third-quarter loss related to the reduced value of its Oak Street Health primary care facilities, but the company is getting a handle on health costs that ha...
CVS raises full-year forecast, takes $5.7 billion impairment charge on health clinics
CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy...
CVS beats estimates, hikes guidance as insurance business improves
CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap...
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
Financial Highlights Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior year Third quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 bill...
CVS Health: Slow And Steady Wins The Healthcare Race
CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and c...
CVS To Close 16 Oak Street Health Centers Amid Industry Cost Issues
CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates across the U.S.
CVS Stock: $31 Bil Shareholder Returns
Over the past ten years, CVS Health stock (NYSE: CVS) has returned $31 billion to shareholders in the form of cash through dividends and buybacks. This shareholder-focused strategy has delivered excep...
US health insurance premiums rose to $27,000 for families in 2025
Annual premiums for U.S. families with employer-sponsored health insurance in 2025 rose 6% to nearly $27,000, reflecting higher spending on popular weight-loss treatments and other prescription drugs,...
CVS Pharmacy Says It Gained 9 Million Former Rite Aid Customers
CVS Pharmacy said it is now serving more than 9 million former Rite Aid and Bartell Drugs patients after completing its acquisition of select assets of the now-closed Rite Aid.
CVS INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into CVS Health Corporation on Behalf of Long-Term Stockholders and Urges Investors to Contact the Firm
CVS allegedly misled investors on its Health Care Benefits segment; rising medical costs and poor forecasts led to repeated guidance cuts and stock drops.
CVS Health Helps Improve Access to More Affordable Fertility Treatments
WOONSOCKET, R.I. , Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Special...
CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers
CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain sa...